Kałka Dariusz, Gebala Jana, Smoliński Ryszard, Rusiecki Lesław, Pilecki Witold, Zdrojowy Romuald
Cardiosexology Unit, Department of Pathophysiology, Wrocław Medical University, Wrocław, Poland; Centre for Men's Health, Wrocław, Poland.
Centre for Men's Health, Wrocław, Poland; Cardiosexology Students' Scientific Club, Wrocław Medical University, Wrocław, Poland.
Urology. 2017 Nov;109:19-26. doi: 10.1016/j.urology.2017.05.030. Epub 2017 May 29.
Patients with cardiovascular disease (CVD) are prone to developing erectile dysfunction (ED) owing to the common risk factors and pathogenesis underlying ED and CVD. As a result, ED affects nearly 80% of male patients with CVD. The efficacy of phosphodiesterase type 5 inhibitors, vacuum erection devices, or intracavernosal injection of vasodilating agents is well established in the treatment of ED; however, their use is limited. Low-energy shock wave therapy is a novel modality that may become a causative treatment for ED. This review aims to assess the efficacy and safety of low-energy shock wave therapy in the treatment of ED in men with CVD.